Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
41
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Verrica Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Aging Global Population And Patient-Friendly Solutions Will Expand Dermatology Markets
Key Takeaways YCANTH's rapid adoption and strong physician engagement position Verrica for outsized revenue growth and market leadership in both pediatric and adult dermatology. Global rights, strategic partnerships, and platform advantages enhance financial stability, open new royalty streams, and could make Verrica an attractive acquisition target.
View narrative
US$30.00
FV
80.1% undervalued
intrinsic discount
155.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Inuvo
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
AI Contextual Targeting Will Expand Global Digital Markets
Key Takeaways Rapid adoption of Inuvo's AI-driven targeting and retention strategies could trigger exponential growth, increased margins, and expanded market share across multiple client segments. Strategic positioning in premium channels and scalable automation poises Inuvo for sustained global expansion, recurring revenue, and long-term margin improvement.
View narrative
US$15.00
FV
75.5% undervalued
intrinsic discount
16.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
U.S. Energy
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Kevin Dome Production Will Benefit From Rising Global Energy Demand
Key Takeaways Vertical integration, new technologies, and strong reserves position U.S. Energy for structurally higher margins and upside from global energy demand shifts. Conservative market expectations overlook the company's earnings potential from infrastructure expansion, cash-rich operations, and strategic acquisition opportunities.
View narrative
US$3.50
FV
65.4% undervalued
intrinsic discount
29.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Owlet
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Connected Health Trends Will Drive Global Infant Monitoring Expansion
Key Takeaways Explosive international growth and strong adoption position Owlet as the leading brand in connected baby monitoring, with substantial potential for outsized revenue and margin expansion. Advanced tech, hospital integration, and premium services could drive high-margin B2B revenue streams and unlock major long-term value from both consumers and healthcare partners.
View narrative
US$15.00
FV
48.3% undervalued
intrinsic discount
21.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Rockwell Medical
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Aging And Home Care Trends Will Raise Demand Amid Risks
Key Takeaways Strong customer diversification, expanding industry contracts, and competitive gains are poised to drive above-expected revenue growth and significant margin expansion. Leading market position and scalable logistics infrastructure position Rockwell to benefit from industry shifts and unlock recurring, higher-margin future revenue streams.
View narrative
US$5.00
FV
79.6% undervalued
intrinsic discount
-13.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Clearside Biomedical
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Aging Global Population Will Boost Ocular Treatment Adoption
Key Takeaways Leading drug delivery technology, strong clinical results, and global partnerships could drive rapid adoption, robust licensing income, and significant revenue and margin expansion. Diversified pipeline and growing disease prevalence ensure long-term product launches, revenue diversification, and strong potential for transformative partnerships with next-generation therapy developers.
View narrative
US$6.00
FV
93.0% undervalued
intrinsic discount
112.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Hyperfine
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Global Aging And Telemedicine Will Drive Portable MRI Adoption
Key Takeaways Rapid clinical adoption, global expansion, and unique use-cases position Swoop for outsized revenue growth and transformative market share gains over traditional MRI. Strong network effects, recurring high-margin revenue, and scalable operations suggest substantial improvement in operating margins and long-term profitability.
View narrative
US$1.50
FV
7.3% undervalued
intrinsic discount
25.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Cibus
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Gene Editing And Climate Resilience Will Redefine Crop Development
Key Takeaways Near-global regulatory harmonization and RTDS platform adoption could rapidly accelerate Cibus' market reach, platform dominance, and recurring margin expansion beyond current analyst expectations. Diversification into sustainable ingredients and gene-editing positions Cibus for strong, stable growth through new high-value partnerships and above-industry-average royalty revenues.
View narrative
US$25.00
FV
94.4% undervalued
intrinsic discount
230.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
LARK Distilling
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Global Premiumization And Destination Tourism Will Spark Lasting Demand
Key Takeaways Transformational brand repositioning, global expansion, and deep inventory could unlock outsized growth and premium brand equity ahead of market expectations. Experiential tourism and innovative product development are poised to drive high-margin direct sales and lasting appeal among younger consumers.
View narrative
AU$3.30
FV
76.8% undervalued
intrinsic discount
35.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies